Skip to main content

“I am a Canadian, free to speak without fear, free to worship in my own way, free to stand for what I think right, free to oppose what I believe wrong, or free to choose those who shall govern my country. This heritage of freedom I pledge to uphold for myself and all mankind.” ~~ John G. Diefenbaker

FRASER INSTITUTE -- Canada’s comparatively weak intellectual property protections limit access to life-saving drugs


Because Canada’s protection of intellectual property in the life sciences—including biology and biochemistry—lags behind other industrialized countries, Canadian patient access to potentially life-saving biologic medicines is comparatively limited, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.

 

“Cutting-edge biologic drugs are treating previously untreatable conditions, often with fewer adverse effects, improving the health of patients and saving lives worldwide,” said Kristina Acri, associate professor of economics at Colorado College, senior fellow at the Fraser Institute and author of Biologics and Biosimilars: A Primer.

 

According to the study, as of December 2018 (the latest month of comparable data), Canada has approved only 10 “biosimilars,” which are versions of biologic drugs, compared to 15 in the United States, 20 in Australia and 62 in the European Union.

 

Biologic drugs are produced from (or contain elements of) living organisms. They are more complicated—and more expensive—to develop, produce, distribute and dispense than other medicines.

 

Subsequently, the ability of drug companies to protect their intellectual property—for example, through data exclusivity, which essentially prevents competing firms from producing generic versions of the drugs for a period of time—is essential for incentivizing the development of biologics, particularly because biopharmaceutical innovations are easily copied and sold by competitors.

 

Unfortunately, Canada’s current intellectual property laws are weak compared to laws in other jurisdictions including the U.S. and EU. For example, Canada has one of the shortest terms of data exclusivity for pre-clinical and clinical trials.

 

“If Canadian policymakers want to improve access to state-of-the-art drugs in Canada, they must strengthen protections for intellectual property,” Acri said.

Labels:

Comments

Post a Comment

Popular posts from this blog

Budget 2027: After a Decade of Decline, NDP Budget Delivers an Assault on Seniors, Working Families, and Small Businesses

Peter Milobar, BC Conservative Finance Critic, condemned the NDP government’s latest budget as the result of a decade of decline that has left British Columbians broke, unsafe, and paying more for less.   “After ten years of NDP mismanagement, this budget is an assault on seniors, working families, and the small businesses that drive our economy,” said Milobar. “The NDP have turned their back on the people working hardest to make ends meet and the seniors who built this province.” Milobar pointed to a new $1.1 billion annual income tax increase and warned that the government is piling new costs onto households already struggling with affordability.   “This government keeps asking British Columbians for more, while delivering less,” Milobar said. “The question people are asking is simple: Where has all the money gone?” Milobar noted that BC has gone from a surplus in the first year of NDP government to a projected deficit of more than $13 billion this year, while prov...
Post a Comment
Read more

WARD STAMER -- Those are REAL forestry numbers, not just made-up numbers

The following is a condensed version of remarks Kamloops – North Thompson MLA Ward Stamer’s made, regarding Forestry, in the BC Legislature, on Tuesday afternoon (02/24/2026)   Let’s talk a little bit, when we talk about Budget 2026, about the forest industry, which is near and dear to my heart. Forestry remains one of British Columbia’s foundational industries. It’s a pillar that built this province. Entire communities depend upon it. Interior towns, northern communities, Vancouver Island regions, the Kootenays, the Lower Mainland, with manufacturing facilities in Surrey and Maple Ridge, just to name a few — everywhere in BC is touched by forestry. One word that was not mentioned in Budget 2026 was forestry. That’s a shame, an incredible shame. It wasn’t an oversight – it was intentional. This government has driven forestry into the ground .... INTO THE GROUND! We can talk a little bit about some of the initiatives that this government has brought forth, to try to resurrect ...
Post a Comment
Read more

FORSETH -- Before anyone gets excited about one poll showing a candidate with a 25 percent lead, and 44 percent support overall, let’s give it a few more weeks

Is this based in reality -- how accurate are the numbers? In the past couple of weeks a couple of candidates, for the leadership of the BC Conservative Party, have been presenting polling results that they lead the pack – one even going so far as to say they have a lock on 44% of those who will be voting, and a twenty-five percent lead over the individual ranked second. I am going to say that this one, from Kerry-Lynne Findlay, is highly suspect. First of all the company conducting the poll, ERG National Research, is not a Member of Industry Bodies (the Canadian Research Insights Council), meaning they do not adhere to established industry standards for research, such as transparency, privacy, and methodological rigor. AI Overview states that ... based on alerts from the Canadian Research Insights Council (CRIC) and reports, ERG National Research should be treated with extreme caution regarding its reliability, and legitimacy, in conducting political polling. Before I even read this in...
Post a Comment
Read more

Labels

Show more